Logo image of JBLU

JETBLUE AIRWAYS CORP (JBLU) Stock Fundamental Analysis

USA - NASDAQ:JBLU - US4771431016 - Common Stock

4.83 USD
+0.13 (+2.77%)
Last: 10/3/2025, 8:00:02 PM
4.8399 USD
+0.01 (+0.2%)
After Hours: 10/3/2025, 8:00:02 PM
Fundamental Rating

2

JBLU gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 21 industry peers in the Passenger Airlines industry. JBLU has a bad profitability rating. Also its financial health evaluation is rather negative. JBLU has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

JBLU had negative earnings in the past year.
JBLU had a negative operating cash flow in the past year.
In the past 5 years JBLU always reported negative net income.
JBLU had a positive operating cash flow in 4 of the past 5 years.
JBLU Yearly Net Income VS EBIT VS OCF VS FCFJBLU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

1.2 Ratios

Looking at the Return On Assets, with a value of -2.28%, JBLU is in line with its industry, outperforming 42.86% of the companies in the same industry.
The Return On Equity of JBLU (-16.03%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -2.28%
ROE -16.03%
ROIC N/A
ROA(3y)-3.24%
ROA(5y)-4.23%
ROE(3y)-16.52%
ROE(5y)-17.71%
ROIC(3y)N/A
ROIC(5y)N/A
JBLU Yearly ROA, ROE, ROICJBLU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 -30

1.3 Margins

Looking at the Gross Margin, with a value of 69.00%, JBLU belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
In the last couple of years the Gross Margin of JBLU has remained more or less at the same level.
JBLU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.27%
GM growth 5Y-1.02%
JBLU Yearly Profit, Operating, Gross MarginsJBLU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

2

2. Health

2.1 Basic Checks

JBLU does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for JBLU has been increased compared to 1 year ago.
JBLU has more shares outstanding than it did 5 years ago.
The debt/assets ratio for JBLU is higher compared to a year ago.
JBLU Yearly Shares OutstandingJBLU Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
JBLU Yearly Total Debt VS Total AssetsJBLU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

JBLU has an Altman-Z score of 0.63. This is a bad value and indicates that JBLU is not financially healthy and even has some risk of bankruptcy.
JBLU has a Altman-Z score (0.63) which is comparable to the rest of the industry.
JBLU has a Debt/Equity ratio of 3.21. This is a high value indicating a heavy dependency on external financing.
JBLU's Debt to Equity ratio of 3.21 is in line compared to the rest of the industry. JBLU outperforms 47.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.21
Debt/FCF N/A
Altman-Z 0.63
ROIC/WACCN/A
WACC5.46%
JBLU Yearly LT Debt VS Equity VS FCFJBLU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

JBLU has a Current Ratio of 0.88. This is a bad value and indicates that JBLU is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.88, JBLU belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
A Quick Ratio of 0.84 indicates that JBLU may have some problems paying its short term obligations.
JBLU has a better Quick ratio (0.84) than 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.84
JBLU Yearly Current Assets VS Current LiabilitesJBLU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for JBLU have decreased strongly by -20.43% in the last year.
The Revenue has decreased by -1.90% in the past year.
The Revenue has been growing slightly by 2.77% on average over the past years.
EPS 1Y (TTM)-20.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
Revenue 1Y (TTM)-1.9%
Revenue growth 3Y15.41%
Revenue growth 5Y2.77%
Sales Q2Q%-2.97%

3.2 Future

JBLU is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.97% yearly.
JBLU is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.10% yearly.
EPS Next Y-130.83%
EPS Next 2Y-19.46%
EPS Next 3Y19.97%
EPS Next 5YN/A
Revenue Next Year-2.29%
Revenue Next 2Y2.13%
Revenue Next 3Y4.1%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
JBLU Yearly Revenue VS EstimatesJBLU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
JBLU Yearly EPS VS EstimatesJBLU Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for JBLU. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for JBLU. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JBLU Price Earnings VS Forward Price EarningsJBLU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as JBLU.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.55
JBLU Per share dataJBLU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

A more expensive valuation may be justified as JBLU's earnings are expected to grow with 19.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-19.46%
EPS Next 3Y19.97%

More info and screens

0

5. Dividend

5.1 Amount

JBLU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

JETBLUE AIRWAYS CORP

NASDAQ:JBLU (10/3/2025, 8:00:02 PM)

After market: 4.8399 +0.01 (+0.2%)

4.83

+0.13 (+2.77%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)10-27 2025-10-27/bmo
Inst Owners77.33%
Inst Owner Change-7.87%
Ins Owners10.1%
Ins Owner Change6.26%
Market Cap1.76B
Analysts46.67
Price Target4.5 (-6.83%)
Short Float %17.48%
Short Ratio3.12
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)29.3%
Min EPS beat(2)5.75%
Max EPS beat(2)52.85%
EPS beat(4)4
Avg EPS beat(4)32.59%
Min EPS beat(4)5.75%
Max EPS beat(4)52.85%
EPS beat(8)7
Avg EPS beat(8)37.53%
EPS beat(12)9
Avg EPS beat(12)25.42%
EPS beat(16)12
Avg EPS beat(16)2.66%
Revenue beat(2)1
Avg Revenue beat(2)-0.61%
Min Revenue beat(2)-2.33%
Max Revenue beat(2)1.12%
Revenue beat(4)1
Avg Revenue beat(4)-0.76%
Min Revenue beat(4)-2.33%
Max Revenue beat(4)1.12%
Revenue beat(8)1
Avg Revenue beat(8)-1.12%
Revenue beat(12)1
Avg Revenue beat(12)-1.31%
Revenue beat(16)2
Avg Revenue beat(16)-1.35%
PT rev (1m)-2.85%
PT rev (3m)-1.17%
EPS NQ rev (1m)8.88%
EPS NQ rev (3m)-24.87%
EPS NY rev (1m)6.72%
EPS NY rev (3m)0.48%
Revenue NQ rev (1m)0.69%
Revenue NQ rev (3m)-0.26%
Revenue NY rev (1m)0.45%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.19
P/FCF N/A
P/OCF N/A
P/B 0.73
P/tB 0.88
EV/EBITDA 11.55
EPS(TTM)-1.12
EYN/A
EPS(NY)-1.03
Fwd EYN/A
FCF(TTM)-3.42
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS25.13
BVpS6.62
TBVpS5.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.28%
ROE -16.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 69%
FCFM N/A
ROA(3y)-3.24%
ROA(5y)-4.23%
ROE(3y)-16.52%
ROE(5y)-17.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.27%
GM growth 5Y-1.02%
F-Score4
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 3.21
Debt/FCF N/A
Debt/EBITDA 14.49
Cap/Depr 178.27%
Cap/Sales 13.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.88
Quick Ratio 0.84
Altman-Z 0.63
F-Score4
WACC5.46%
ROIC/WACCN/A
Cap/Depr(3y)199.72%
Cap/Depr(5y)186.25%
Cap/Sales(3y)13.36%
Cap/Sales(5y)16.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
EPS Next Y-130.83%
EPS Next 2Y-19.46%
EPS Next 3Y19.97%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.9%
Revenue growth 3Y15.41%
Revenue growth 5Y2.77%
Sales Q2Q%-2.97%
Revenue Next Year-2.29%
Revenue Next 2Y2.13%
Revenue Next 3Y4.1%
Revenue Next 5YN/A
EBIT growth 1Y46.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year263.73%
EBIT Next 3Y89.31%
EBIT Next 5YN/A
FCF growth 1Y-317.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-106.33%
OCF growth 3Y-55.57%
OCF growth 5Y-36.98%